Correlation Between Legend Biotech and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Legend Biotech and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Legend Biotech and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Legend Biotech Corp and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Legend Biotech and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Legend Biotech with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Legend Biotech and Alnylam Pharmaceuticals.
Diversification Opportunities for Legend Biotech and Alnylam Pharmaceuticals
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Legend and Alnylam is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Legend Biotech Corp and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Legend Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Legend Biotech Corp are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Legend Biotech i.e., Legend Biotech and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Legend Biotech and Alnylam Pharmaceuticals
Given the investment horizon of 90 days Legend Biotech Corp is expected to under-perform the Alnylam Pharmaceuticals. In addition to that, Legend Biotech is 1.02 times more volatile than Alnylam Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about 0.02 per unit of volatility. If you would invest 22,414 in Alnylam Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 2,075 from holding Alnylam Pharmaceuticals or generate 9.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Legend Biotech Corp vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Legend Biotech Corp |
| Alnylam Pharmaceuticals |
Legend Biotech and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Legend Biotech and Alnylam Pharmaceuticals
The main advantage of trading using opposite Legend Biotech and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Legend Biotech position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Legend Biotech vs. Eliem Therapeutics | Legend Biotech vs. HCW Biologics | Legend Biotech vs. Scpharmaceuticals | Legend Biotech vs. Milestone Pharmaceuticals |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |